The Procter & Gamble Company (PG) Financial Statements
The Procter & Gamble Company (PG) reported trailing twelve-month revenue of $87.9B (up 3.5% year on year) and net income of $16.0B as of 2026-09-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $15.3B.
Source: SEC EDGAR filings · figures as of 2026-09-30 · read by EquiReason
PGThe Procter & Gamble CompanyFollow PG — free
—
Price chart with a free account
- Market cap
- 373.2B
- P/E TTM
- 24.3
- Dividend yield
- 2.7%
- 52-week
- —
- Next earnings
- 20 Jan, in 88 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Sep 26.
| Line | FY2010 Jun 10 | FY2011 Jun 11 | FY2012 Jun 12 | FY2013 Jun 13 | FY2014 Jun 14 | FY2015 Jun 15 | FY2016 Jun 16 | FY2017 Jun 17 | FY2018 Jun 18 | FY2019 Jun 19 | FY2020 Jun 20 | FY2021 Jun 21 | FY2022 Jun 22 | FY2023 Jun 23 | FY2024 Jun 24 | FY2025 Jun 25 | FY2026 Jun 26 | TTM Sep 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 77.57 | 81.10 | 82.01 | 80.12 | 74.40 | 70.75 | 65.30 | 65.06 | 66.83 | 67.68 | 70.95 | 76.12 | 80.19 | 82.01 | 84.04 | 84.28 | 87.03 | 87.92 | |
| Gross profit | 40.53 | 41.25 | 40.60 | 40.13 | 35.37 | 33.69 | 32.39 | 32.52 | 32.56 | 32.92 | 35.70 | 39.01 | 38.03 | 39.25 | 43.19 | 43.12 | 43.67 | 43.77 | |
| Research & development | — | — | — | 1.90 | 1.90 | 2.00 | 1.90 | 1.90 | 1.90 | 1.90 | 1.80 | 1.90 | 2.00 | 2.00 | 2.00 | 2.10 | 2.10 | — | |
| Operating income | 15.73 | 15.50 | 13.04 | 13.82 | 13.91 | 11.05 | 13.44 | 13.77 | 13.36 | 5.49 | 15.71 | 17.99 | 17.81 | 18.13 | 18.55 | 20.45 | 19.75 | 19.83 | |
| Pre-tax income | 14.87 | 15.00 | 12.53 | 14.18 | 13.51 | 11.01 | 13.37 | 13.26 | 13.33 | 6.07 | 15.83 | 17.62 | 18.00 | 18.35 | 18.76 | 20.17 | 20.38 | 20.37 | |
| Income tax | 4.02 | 3.30 | 3.38 | 3.23 | 2.85 | 2.73 | 3.34 | 3.06 | 3.47 | 2.10 | 2.73 | 3.26 | 3.20 | 3.62 | 3.79 | 4.10 | 4.23 | 4.25 | |
| Net income | 12.74 | 11.80 | 10.76 | 11.31 | 11.64 | 7.04 | 10.51 | 15.33 | 9.75 | 3.90 | 13.03 | 14.31 | 14.74 | 14.65 | 14.88 | 15.97 | 16.05 | 16.03 | |
| Diluted EPS ($) | 4.11 | 3.93 | 3.66 | 3.86 | 4.01 | 2.44 | 3.69 | 5.59 | 3.67 | 1.43 | 4.96 | 5.50 | 5.81 | 5.90 | 6.02 | 6.51 | 6.62 | 6.64 | |
| Diluted shares (bn) | 3.099 | 3.002 | 2.941 | 2.931 | 2.905 | 2.884 | 2.844 | 2.740 | 2.657 | 2.539 | 2.626 | 2.601 | 2.539 | 2.484 | 2.472 | 2.454 | 2.422 | — |
USD billions · SEC XBRL
The Procter & Gamble Company — questions
- What is The Procter & Gamble Company's revenue?
- $87.9B over the twelve months to 2026-09-30, up 3.5% year on year, from its 10-Q and 10-K filings.
- What is The Procter & Gamble Company's net income?
- $16.0B over the twelve months to 2026-09-30.
- What is The Procter & Gamble Company's free cash flow?
- $15.3B over the twelve months to 2026-09-30.
- What are The Procter & Gamble Company's diluted earnings per share?
- $6.64 over the twelve months to 2026-09-30.
Every figure on this page comes from The Procter & Gamble Company's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.